Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP307608.RAAaoJtB1kgOUOr8Z8llns3LwLe9Xj_bK2sjPWKeGJLI4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP307608.RAAaoJtB1kgOUOr8Z8llns3LwLe9Xj_bK2sjPWKeGJLI4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP307608.RAAaoJtB1kgOUOr8Z8llns3LwLe9Xj_bK2sjPWKeGJLI4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP307608.RAAaoJtB1kgOUOr8Z8llns3LwLe9Xj_bK2sjPWKeGJLI4130_provenance.
- NP307608.RAAaoJtB1kgOUOr8Z8llns3LwLe9Xj_bK2sjPWKeGJLI4130_assertion description "[This review surveys a range of approaches using plasmid DNA encoding the 165-amino-acid isoform of vascular endothelial growth factor (phVEGF165) to therapeutically modulate micro- or macrovascular endothelial cells, focusing on strategies to augment postnatal collateral circulation in arterial insufficiency or to accelerate re-endothelialization after balloon angioplasty to prevent restenosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307608.RAAaoJtB1kgOUOr8Z8llns3LwLe9Xj_bK2sjPWKeGJLI4130_provenance.
- NP307608.RAAaoJtB1kgOUOr8Z8llns3LwLe9Xj_bK2sjPWKeGJLI4130_assertion evidence source_evidence_literature NP307608.RAAaoJtB1kgOUOr8Z8llns3LwLe9Xj_bK2sjPWKeGJLI4130_provenance.
- NP307608.RAAaoJtB1kgOUOr8Z8llns3LwLe9Xj_bK2sjPWKeGJLI4130_assertion SIO_000772 11181962 NP307608.RAAaoJtB1kgOUOr8Z8llns3LwLe9Xj_bK2sjPWKeGJLI4130_provenance.
- NP307608.RAAaoJtB1kgOUOr8Z8llns3LwLe9Xj_bK2sjPWKeGJLI4130_assertion wasDerivedFrom befree-2016 NP307608.RAAaoJtB1kgOUOr8Z8llns3LwLe9Xj_bK2sjPWKeGJLI4130_provenance.
- NP307608.RAAaoJtB1kgOUOr8Z8llns3LwLe9Xj_bK2sjPWKeGJLI4130_assertion wasGeneratedBy ECO_0000203 NP307608.RAAaoJtB1kgOUOr8Z8llns3LwLe9Xj_bK2sjPWKeGJLI4130_provenance.
- befree-2016 importedOn "2016-02-19" NP307608.RAAaoJtB1kgOUOr8Z8llns3LwLe9Xj_bK2sjPWKeGJLI4130_provenance.